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ABSTRACT. A series of enantiopure hydroxy esters and lactones has been synthesized in a 
chemodivergent manner via alcohol dehydrogenase (ADH) reduction of the corresponding keto 
esters by means of cascade or tandem protocols. Thus, ADH from Rhodococcus ruber (ADH-A) 
or Lactobacillus brevis (LBADH) afforded both antipodes in a very selective way when dealing 
with small derivatives. With bulkier substrates, ADH from Ralstonia sp. (RasADH) was 
successfully employed to achieve the synthesis of enantioenriched γ- or δ-hydroxy esters. To 
isolate the corresponding lactones, two different approaches were followed: a cascade reaction 
by spontaneous cyclization of the hydroxy ester intermediate, or a one-pot two-step tandem 
protocol. Moreover, a chemoenzymatic route was designed to obtain a chiral brominated lactone 
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which enabled further modifications in a sequential fashion by Pd-catalyzed reactions affording 
relevant functionalized lactones. 
Introduction 
The preparation of γ- and δ-lactones has attracted increasing attention because of their 
structural implications as basic chemicals but also as valuable building blocks for polymers and 
natural product synthesis. These compounds display a broad biological profile and are also 
important flavor and aroma constituents.
1
 In particular, γ-valerolactone (GVL) has been 
identified as a potential intermediate for the production of fuels,
2
 while δ-caprolactone is used as 
monomer to synthesize biodegradable polymers.
3
 On the other hand, enantioenriched γ- or δ-
hydroxy esters are present in many bioactive molecules such as polyketides, prostaglandins, 
pheromones and other important compounds.
4
 
Owing to their unsurpassed selectivity, biocatalytic approaches (Scheme 1) have rapidly 
gained ground in the synthesis of these enantioenriched derivatives. Among them, the Baeyer-
Villiger monooxygenase (BVMO) oxidation of racemic or prochiral cyclic ketones,
5
 the 
hydrolase-catalyzed kinetic resolutions (KRs) starting from the corresponding racemic lactones
6
 
or the hydroxy ester precursors,
7
 and the enantioselective alcohol dehydrogenase (ADH)-
catalyzed oxidation of racemic diols can be mentioned.
8,9
 Alternatively, dynamic systems 
(DKRs) using lipases with a metal-based racemization have also been studied to quantitatively 
yield the enantiopure products.
10
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Scheme 1. General biocatalytic approaches to achieve γ- or δ-lactones. 
 
Another straightforward route to obtain such enantioenriched derivatives is the direct ADH-
catalyzed bioreduction of γ- or δ-keto esters. In this sense, the first protocols were traditionally 
done employing whole-cell systems,
11
 but in general selectivities or substrate concentrations 
were not satisfactory. Furthermore, in most cases mixtures of the lactone and the corresponding 
hydroxy ester were detected. Although some of these drawbacks were overcome using isolated 
enzymes, the hitherto reported methodologies only led to the (S)-antipodes in an efficient 
manner.
12
 More recently, Pietruszka and co-workers described the enzymatic synthesis of several 
γ- or δ-hydroxy esters, and then different lactones were obtained in a multi-step route.13 
As a part of our ongoing interest in the field of one-pot cascade or sequential transformations,
14
 
and due to the rise of methodologies that have elegantly combined the use of alcohol 
dehydrogenases with organo- or metal-catalyst(s),
15
 we have considered worthwhile an 
exploration of the bioreduction of several γ- and δ-keto esters to: (i) find a chemoselective and 
efficient approach to get access to the lactones or the hydroxy esters; (ii) search for recombinant 
ADHs able to afford these products in a stereodivergent fashion allowing the synthesis of both 
antipodes; and (iii) combine a bioreductive cascade with several Pd-based transformations to 
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expand the scope and potential of these protocols applied to the formation of highly valuable 
lactones. 
 
Results and Discussion 
Thus, we first focused on the bioreduction of several prochiral γ- and δ-keto esters 1a-g 
(Scheme 2) studying different biocatalysts and reaction conditions such as pH. In an initial set of 
experiments, a number of recombinant ADHs were screened for activity towards the 
bioreduction of methyl 5-oxohexanoate (1a, 50 mM) at pH 9.0 and 30ºC. For some of them 2-
propanol (2-PrOH) was used as hydrogen donor to recycle the nicotinamide cofactor, while for 
other glucose and glucose dehydrogenase (GDH) were employed. 
 
Scheme 2. Biosynthesis of enantioenriched γ- and δ-hydroxy esters and lactones using an ADH-
based one-pot cascade or tandem strategy. 
 
 
Although good activities were detected with several alcohol dehydrogenases (see Supporting 
Information), only ADH from Rhodococcus ruber (ADH-A)
16
 and ADH from Lactobacillus 
brevis (LBADH)
17
 showed excellent stereoselectivities (ee >99%). Furthermore, due to the fact 
that these enzymes display opposite selectivities, the formation of both enantiomers of methyl 5-
hydroxyhexanoate (2a) and δ-caprolactone (3a) was feasible. For these reasons, ADH-A and 
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LBADH were selected for further investigations. In a subsequent study, the effect of the pH was 
examined in order to check whether this parameter could shift the equilibrium towards the 
formation of either of the two possible products. Thus, these bioreductions were performed at pH 
5.0, 7.5 and 9.0 (Figure 1). Gratifyingly, neutral pH was found as the best one to form 
preferentially hydroxy ester 2a over lactone 3a, while a higher pH led to noticeable amounts of 
3a with both ADHs (c >18%), corresponding to the intramolecular cyclization of the hydroxy 
ester intermediate in a cascade fashion. A lower pH inhibited the formation of lactone 3a also at 
expenses of the enzymatic activity. 
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Figure 1. Effect of the pH in the ADH-catalyzed bioreduction of 1a (50 mM, t= 24 h). In blue, 
results obtained for ADH-A and in red for LBADH. In all cases ee of the final products were 
>99%. 
Next, the effect of the chain length (γ- vs δ-keto ester) and the ester moiety (Me vs Et) were 
studied with both biocatalysts. Thus, bioreductions were performed over ethyl 5-oxohexanoate 
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(1b), methyl levulinate (1c) and ethyl levulinate (1d). From these experiments, two trends 
appeared clear: a) the intramolecular cyclization to afford the desired lactones was highly 
favored for the 5-membered ring (compare formation of 3a vs 3c in Figure 2); and b) the 
cyclization rate was enhanced for methyl ester derivatives (thus producing MeOH), compared to 
the ethyl esters (where EtOH was formed), since the transformation into lactone 3a starting from 
1a was faster than from 1b. The same tendency was observed for γ-valerolactone (3c) starting 
from 1c or 1d with both ADHs. Additionally, enantiomeric excess was >99% in all cases, getting 
access to both antipodes of the corresponding hydroxy ketones 2a and 2b or lactones 3a and 3c. 
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Figure 2. Effect of the alkyl chain length and the ester moiety in the ADH-catalyzed 
bioreduction of 1a-d (50 mM) at 30ºC and pH 9.0 for: a) ADH-A; and b) LBADH. In all cases ee 
of the final products were >99%. 
 
Due to the drastic influence of the pH in the cyclization process, we designed a one-pot two-
step tandem protocol to achieve the synthesis of δ-caprolactone 3a. It was envisaged that acidic 
treatment of the reaction mixture of 2a and 3a after the ADH-catalyzed bioreduction of 1a could 
led to 3a without losing the excellent stereopreference. Thus after enzymatic reduction, a 
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solution of HCl 1 M was added to the reaction medium, exclusively detecting lactone 3a after 24 
h (ee >99%). In the case of γ-keto esters 1c and 1d, GVL 3c was obtained as major product 
recycling the cofactor by simple addition of 2-PrOH and without the need of adding HCl. It is 
important to remark that these findings could be reproduced on a 300 mg scale, achieving 
enantioenriched (R)-GVL employing LBADH as biocatalyst in 93% conversion and 97% ee (see 
SI for more details). Using this methodology, both enantiomers of 3c could be easily obtained in 
a one-pot cascade fashion performing the bioreduction at 30ºC and pH 9.0. To summarize this 
part, it is worth mentioning that depending on the reaction conditions we could control the 
synthesis of the hydroxy esters 2a or 2b or the lactone 3a in a chemo- and stereodivergent 
manner. In the case of γ-keto esters, the formation of the lactone was highly favored thus 
synthesizing both enantiomers of GVL 3c with high efficiency at slightly basic pH. Furthermore, 
traces coming from the hydrolysis of the staring material could be just detected.
18
 
At this point, we decided to test a bulkier substrate such as methyl 5-oxo-5-phenylpentanoate 
(1e, Scheme 3). With this goal in mind, we used ADHs from Sphingobium yanoikuyae 
(SyADH)
19
 and Ralstonia sp. ADH (RasADH)
20
 overexpressed in E. coli, since the substrate 
spectra for these enzymes is known to cover similar ‘bulky-bulky’ ketones. 2-PrOH was 
employed as cosubstrate for E. coli/SyADH, whereas the glucose/GDH system was chosen in the 
case of E. coli/RasADH. Based on previous results, we performed the reduction of 1e at pH 7.5 
with both enzymes to obtain hydroxy ester 2e preferentially. Thus, while E. coli/RasADH led to 
the enantiomer (R)-2e
21
 with an excellent conversion (>97%) and ee values (>99%), E. 
coli/SyADH led also to (R)-2e with a moderate conversion of 52% with a high enantiomeric 
excess (95%). In this case the cyclization process using HCl 1 M did not work properly, attaining 
less than 25% conversion of lactone 3e. 
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When the aromatic γ-keto ester 1f was used as substrate, in contrast to compounds 1c and 1d 
only hydroxy ester 2f was detected. Taken together, these results emphasize the relevance of the 
keto ester structure in order to favor (or not) the lactonization process. In this case, E. 
coli/RasADH was the most effective in terms of conversion and enantioselectivity towards (R)-2f 
(c= 97%, ee= 99%), since SyADH afforded very low conversions (<20%) at pH 7.5. It is 
noteworthy that 2f is a valuable precursor for the preparation of γ-peptides22 and is also present 
in the structure of cryptophycin,
23
 a potent cytotoxic drug. In order to shift the equilibrium 
towards the formation of lactone 3f, an acidic treatment with HCl 1 M was required. When these 
bioreductions were tried at pH 9.0 to favor the cyclization, slightly lower ee values (~90%) were 
attained with both biocatalysts towards hydroxy ester 2f, due to a racemization issue (vide infra), 
although complete conversion could be achieved with E. coli/SyADH in this case. As a matter of 
fact, depending on the pH or the substrate structure, hydroxy esters 2 or lactones 3 can be 
preferentially formed in a chemodivergent manner through one-pot cascade or tandem protocols 
(Scheme 3). 
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Scheme 3. Chemo- and stereodivergent synthesis of γ- and δ-hydroxy esters and lactones 
through ADH-catalyzed reactions. 
 
 
Once found the appropriate conditions to get access to enantioenriched hydroxy esters or 
lactones, we decided to apply this biocatalytic method to the synthesis of several bioactive 
derivatives. Therefore, the bioreduction of brominated compound 1g was studied since lactone 
3g has been used as intermediate for the synthesis of γ-hydroxybutyric acid (GHB) analogues for 
high-affinity GHB sites and γ-aminobutyric acid (GABA) receptors.24 Based on our previous 
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results, E. coli/RasADH was selected as the biocatalyst to achieve this transformation with 
glucose and GDH to recycle the cofactor. In order to obtain the corresponding lactone, the 
reduction was firstly tried under basic conditions (pH 9.0). Unfortunately, we observed that the 
corresponding hydroxy ester 2g and the lactone 3g were accessed with very low ee values. After 
confirming that other ADHs from the E. coli host were not involved in the non-stereoselective 
bioreduction of this substrate, we decided to study this process in more detail following the 
reduction within the time (Figure 3). As depicted in Figure 3, ee values from both 2g and 3g 
decreased along the reaction. Control experiments indicated that racemization of hydroxy ester 
2g occurred in basic medium while lactone 3g remained unaltered. 
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Figure 3. Time study of the E. coli/RasADH-catalyzed bioreduction of 1g at 30ºC and pH 9.0. 
 
With the goal of avoiding this undesired process, the bioreduction was performed at pH 7.5. 
Under these conditions, RasADH showed high activity (c >99%) and (R)-2g could be obtained 
with an excellent selectivity (ee >97%) after 4 h. Again acidic treatment with HCl 1 M led to the 
corresponding lactone with identical ee value. Due to the easy handling of E. coli lyophilized 
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cells, a preparative preparation of (R)-3g could be readily achieved in a one-pot two-step tandem 
protocol on a 200 mg scale (50 mM), thus attaining the desired compound with excellent isolated 
yield (95%) and ee (97%). Notably, this methodology improves the previously described 
protocols for the preparation of brominated lactone (R)-3g.
7a,25
 Interestingly, SyADH gave access 
to the opposite enantiomer, (S)-3g, with complete conversion although with a lower 
stereoselectivity (ee= 60%). 
 
Scheme 4. Chemodiverse preparation of (R)-4g, (R)-5g and (R)-6g combining a one-pot 
enzymatic protocol with Pd-based catalysis. 
 
 
 
After these promising results with RasADH, we focused on the subsequent functionalization of 
the brominated lactone in order to expand the applicability of this methodology. Based on the 
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nature of the substrate, we employed Pd-coupling reactions to construct more complex and 
potentially bioactive lactones (Scheme 4).
24,26
 We first attempted the Suzuki coupling starting 
from racemic 3g with phenylboronic acid using Pd(PPh3)2Cl2 since this catalyst showed good 
activities in aqueous media.
15b
 We were pleased to find that such a reaction was compatible with 
the stability of the lactone, achieving compound 4g with an excellent conversion (>98%). 
However, when both steps were combined in one-pot only traces of the coupled product was 
detected. This result probably arose from inhibition issues. The reaction was therefore performed 
in a sequential manner. After bioreduction, the crude was simply extracted and then treated under 
Suzuki conditions obtaining (R)-4g in 75% conversion. In a similar manner, Sonogashira and 
Heck coupling were attempted. In the first case, Pd(PPh3)2Cl2 and CuI were used to couple 
lactone (R)-3g with phenylacetylene at 100ºC affording derivative (R)-5g in a 60% isolated yield, 
while for the Heck transformation, Pd(OAc)2 and styrene were employed at 120ºC to achieve 
lactone (R)-6g with a 69% conversion. Remarkably, all three Pd-catalyzed reactions proceeded 
smoothly getting access to compounds (R)-4g-6g without losing enantioselectivity. 
 
Conclusions 
In summary, we have demonstrated that ADHs can be used for the chemo- and stereodivergent 
synthesis of relevant hydroxy esters and lactones in ee >97% through direct bioreduction, or by 
means of cascade and tandem protocols by simply tuning the reaction conditions. Also, the 
substrate structure was a key factor in the spontaneous cyclization process. ADH-A or LBADH 
were used to reduce selectively methyl ketone substrates, whereas levulinate compounds 
afforded the formation of (S)- or (R)-GVL, 5-oxohexanoate surrogates preferentially gave access 
to the corresponding (S)- or (R)-δ-hydroxy esters. In these latter cases, an acid-catalyzed 
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cyclization step was necessary in order to isolate the six-membered ring lactones. For bulkier 
substrates RasADH or SyADH were employed, and after bioreduction the corresponding (R)-γ-
hydroxy esters were efficiently obtained. After acidic treatment the five-membered ring lactone 
could be achieved. 
These findings have been applied to the preparation of relevant compounds simplifying the 
previous established methods. Furthermore, the viability of this synthetic route prompted us the 
one-pot two-step chemoenzymatic preparation of an enantioenriched brominated lactone that 
allowed the divergent synthesis of several functionalized chiral lactones with potential biological 
properties by sequential Pd-catalyzed transformations. Our approach is efficient, simple and 
scalable having great potential as a “greener” protocol. 
 
Experimental Section 
General considerations 
Glucose dehydrogenase (GDH 106, 54 U mg
-1
), ADH-A from Rhodococcus ruber (20 U mg
-1
), 
and LBADH from Lactobacillus brevis (80 U mg
-1
) were obtained from Codexis. ADHs from 
Rhodococcus ruber (ADH-A), Thermoanaerobacter ethanolicus (TeSADH), Sphingobium 
yanoikuyae (SyADH) and Ralstonia sp. (RasADH) have been obtained from Prof. Wolfgang 
Kroutil at the University of Graz and have been overexpressed following the methodology 
previously described.
19,20,27
 
NMR spectra were recorded on a 300 MHz, 400 MHz or 600 MHz spectrometers. All 
chemical shifts (δ) are given in parts per million (ppm) and are referenced to the residual solvent 
signal as internal standard. The following abbreviation is employed: m= multiplet. Gas 
chromatography (GC) analyses were performed on a standard GC chromatograph equipped with 
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FID. High performance liquid chromatography (HPLC) analyses were carried out in a standard 
chromatograph coupled to a UV detector at 210 nm. High resolution mass spectra (HRMS) were 
obtained using a spectrometer by positive electrospray ionization (ESI
+
). IR spectra were 
recorded as thin films on NaCl plates on a standard FT-IR and are reported in frequency of 
absorption (cm
-1
). Thin-layer chromatography (TLC) was conducted with silica gel precoated 
plates and visualized using a UV lamp and/or potassium permanganate stain. Column 
chromatography was performed using silica gel (230-400 mesh). Microwave reactions were 
carried out with a standard microwave apparatus with high stirring. Optical rotations were 
measured in a polarimeter and values are reported in 10
-1
 deg cm
2
 g
-1
 (concentration, solvent). 
Protocol using ADH from Lactobacillus brevis (LBADH) 
In a 10 mL vial, LBADH (7.5 U) was dissolved in Tris-HCl buffer (50 mM, pH 5.0-9.0, 2.28 
mL, 1 mM NADPH, 1 mM MgCl2), 2-PrOH (120 μL, 5% v v
-1
) and the corresponding keto ester 
(50 mM). The reaction was shaken at 30ºC and 250 rpm for 24 h. The reaction mixture was 
extracted with Et2O (3 x 2 mL). The organic layers were combined and dried over Na2SO4. The 
solvent was carefully evaporated and the conversion of the corresponding hydroxy ester or 
lactone was determined by NMR and the ee by GC or HPLC. 
Protocol using ADH from Rhodococcus ruber (ADH-A) 
In a 10 mL vial, ADH-A (3 U) was dissolved in Tris-HCl buffer (50 mM, pH 5.0-9.0, 2.28 mL, 
1 mM NADH), 2-PrOH (120 μL, 5% v v-1) and the corresponding keto ester (50 mM). The 
reaction was shaken at 30ºC and 250 rpm for 24 h. The reaction mixture was extracted with Et2O 
(3 x 2 mL). The organic layers were combined and dried over Na2SO4. The solvent was carefully 
evaporated and the conversion of the corresponding hydroxy ester or lactone was determined by 
NMR and the ee by GC or HPLC. 
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Protocol using ADH from Ralstonia sp. (E. coli/RasADH) 
In a 10 mL vial, E. coli/RasADH (50 mg) was resuspended in Tris-HCl buffer 50 mM pH 7.5-
9.0 (2.28 mL, 1 mM NADPH), glucose (100 mM), glucose dehydrogenase (GDH, 5 U), and the 
corresponding keto ester (50 mM). The reaction was shaken at 30ºC and 250 rpm for 24 h and 
stopped by extraction with Et2O (3 x 2 mL). The organic layers were combined and dried over 
Na2SO4. The solvent was carefully evaporated and the conversion of the corresponding hydroxy 
ester or lactone was determined by NMR and the ee by GC or HPLC. 
Chemoenzymatic one-pot two-step protocol to obtain enantiopure lactone 3a 
In a 10 mL vial, LBADH (7.5 U) was dissolved in Tris-HCl buffer (50 mM, pH 9.0, 2.28 mL, 
1 mM NADPH, 1 mM MgCl2), 2-PrOH (120 μL, 5% v v
-1
) and the corresponding keto ester 1a-
b (50 mM). The reaction was shaken at 30ºC and 250 rpm for 24 h. Then, a solution of HCl 1 M 
(2 mL) was added into the reaction mixture and was shaken at 30ºC and 250 rpm for 24 
additional hours. The reaction mixture was extracted with Et2O (3 x 2 mL). The organic layers 
were combined and dried over Na2SO4. The solvent was carefully evaporated and the conversion 
of the reaction was determined by NMR (>97%) and the ee by GC or HPLC (>97%). 
Scale-up of the preparation of (R)-GVL using LBADH 
In a 50 mL Erlenmeyer flask, LBADH (140 U) was dissolved in a Tris-HCl buffer solution (50 
mM, pH 9, 17 mL, 1 mM NADPH, 1 mM MgCl2) containing 2-PrOH (2.4 mL, 5% v v
-1
) and 
methyl levulinate 1a (295 L, 100 mM). The reaction was shaken at 30ºC and 250 rpm for 24 h. 
The reaction mixture was then extracted with Et2O (3 x 20 mL). The organic layers were 
combined, dried over Na2SO4 and the solvent carefully evaporated. (R)-3a was obtained in 
quantitative yield with a purity of 93% (ee = 97%). 
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Scale-up of the enzymatic reaction to obtain (R)-3g with E. coli/RasADH 
In a 50 mL Erlenmeyer flask, E. coli/RasADH cells (250 mg) were resuspended in a Tris-HCl 
buffer solution (50 mM, pH 7.5, 11.4 mL, 1 mM NADPH) containing glucose (100 mM), GDH 
(200 U), 2-PrOH (600 μL, 5% v v-1), and 1g (200 mg, 50 mM). The reaction was shaken at 30ºC 
and 250 rpm for 24h. After that time, 10 mL of HCl 1M were added and the reaction mixture 
was shaken at 30ºC and 250 rpm for 24 additional hours. The reaction mixture was then 
extracted with Et2O (3 x 10 mL). The organic layers were combined and dried over Na2SO4. The 
crude residue was purified by chromatography column (20% EtOAc/hexane) isolating the 
corresponding lactone (R)-3g in 95% yield (ee = 97%), [α]D
20
 = -24.7 (c 1.23, CHCl3). Spectral 
data for 3g were consistent with those reported in the literature.
24
 
Sequential reaction using the Suzuki coupling for the synthesis of (R)-4g 
In a 50 mL erlenmeyer, E. coli/RasADH cells (125 mg) were resuspended in Tris-HCl buffer 
(50 mM, pH 7.5, 4.5 mL, 1 mM NADPH), containing glucose (400 mM), GDH (20 U), 2-PrOH 
(300 μL, 5% v v-1), and 1g (81.3 mg, 0.3 mmol). The reaction was shaken at 250 rpm for 24 h at 
30ºC. The resulting mixture was treated with 5 mL of HCl (1 M) and stirred for additional 24 h. 
After that time, the reaction was centrifuged (5 min, 4000 rpm) and the cell pellet was washed 
with EtOAc (3 x 20 mL). The organic layers were combined and dried over Na2SO4 and the 
solvent was evaporated. The resulting crude mixture was dissolved in Tris-HCl buffer (16 mL, 
50 mM, pH 7.5) and 2-PrOH (1.6 mL, 10% v v
-1
) and treated with phenylboronic acid (63 mg, 
0.50 mmol) and K2CO3 (92 mg, 0.66 mmol). Then, Pd(PPh3)2Cl2 (11.4 mg, 0.016 mmol) was 
added and the resulting mixture was stirred for 24 h at 45ºC. The reaction mixture was extracted 
with EtOAc (3 x 15 mL) and the combined organic phases dried over Na2SO4 and concentrated 
in vacuo. The crude was analyzed by NMR observing the formation of lactone (R)-4g in a 75% 
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conversion (ee = 97%). Spectral data for 4g were consistent with those reported in the 
literature.
28
 
Sequential reaction using the Sonogashira coupling for the synthesis of (R)-5g 
The corresponding brominated lactone rac- or (R)-3g (40 mg, 0.166 mmol), Pd(PPh3)2Cl2 (4.7 
mg, 0.007 mmol) and CuI (1.9 mg, 0.01 mmol) were added to a sealed tube under a stream of 
nitrogen and dissolved in a mixture DMF/Et3N (1 mL, 5:3 v v
-1
). To the stirred solution 
phenylacetylene (27 µL, 0.249 mmol) was added. The reaction mixture was heated at 100ºC for 
16 h. After that time, the reaction mixture was extracted with EtOAc (3 x 10 mL). The organic 
layers were combined and dried over Na2SO4. The crude residue was purified by column 
chromatography (20% EtOAc/hexane) isolating the corresponding lactone 5g in 58-64% isolated 
yield. 
1
H NMR (400 MHz, CDCl3): δ 2.21 (m, 1H), 2.68 (m, 3H), 5.54 (m, 1H), 7.36 (m, 6H, Ar), 
7.55 (m, 4H, Ar); 
13
C NMR (106 MHz, CDCl3): δ 176.6, 139.4, 132.0 (2C), 131.6 (2C), 128.4 
(2C), 126.9, 125.2 (2C), 123.5, 123.0, 90.0, 88.7, 80.8, 30.9, 28.9; IR (neat): 3026, 2920, 2845, 
1653, 1600, 1494, 1449, 1260, 1068, 1022 cm
-1
. MS (APCI
+
, m/z) 263.0 [(M+H)
+
, 100%]. 
Sequential reaction using the Heck coupling for the synthesis of (R)-6g 
The corresponding brominated lactone rac- or (R)-3g (40 mg, 0.166 mmol), Pd(OAc)2 (1.9 mg, 
0.008 mmol) and H3PO4 (2.4 mmol) were added to a sealed tube under a stream of nitrogen and 
dissolved in THF (1 mL). To the stirred solution styrene (28 L, 0.249 mmol) was added. The 
reaction mixture was heated at 120ºC for 16 h. The reaction mixture was then extracted with 
EtOAc (3 x 10 mL). The organic layers were combined and dried over Na2SO4 and the crude 
residue was analyzed by NMR observing the formation of lactone (R)-6g in a 69% conversion 
(ee = 97%). Spectral data for 6g were consistent with those reported in the literature.
24
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Supporting Information. Experimental procedures, enzymatic protocols at higher substrate 
concentrations, analytical data, and copies of 
1
H- and 
13
C-NMR for 5g are described. This 
information is available free of charge via the Internet at http://pubs.acs.org. 
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